https://it.marketscreener.com/quotazioni/azione/INNOVENT-BIOLOGICS-INC-49476402/attualita/Innovent-Biologics-Inc-annuncia-che-lo-studio-clinico-di-Fase-3-di-Ibi311-ha-raggiunto-l-endpoint-45986363/?utm_source=telegram&utm_medium=social&utm_campaign=share